Skip to content

Add your earlier progress to your account?

From before you signed in, this browser has:

Which plan do you want to keep?

You answered the plan questions before signing in. These answers differ from the plan saved on your account.

SettingSaved planNew answers

Study progress is waiting to be saved

Blood Group Foundations and Carbohydrate Systems

About 16 min · 14 sections · 3 self-checks

On this page

An ABO group that does not agree front to back, or a phenotype that does not fit the history, sends the investigation back to inheritance and antigen construction. Routine serology establishes a red-cell phenotype and may support more than one genotype. The distinction matters when an inherited enzyme, a precursor antigen, developmental expression, or recent transfusion changes the expected reaction pattern. Molecular or family studies can resolve selected cases that serology cannot.

Inheritance, phenotype, and prediction

Genetic vocabulary

A gene occupies a defined chromosomal locus. Alternative sequences at that locus are alleles. A person's genotype is the inherited allele combination, and the phenotype is the antigen expression observed or predicted from that combination. Routine serology shows which antigens are expressed and may suggest a probable genotype. Family studies or molecular testing can establish the genotype.1,2

Term Meaning in blood group genetics Example
Homozygous The two alleles at a locus are the same OO at the ABO locus
Heterozygous The two alleles at a locus differ AO or AB
Hemizygous Only one copy of a locus is present An X-linked locus in a typical XY individual
Codominant Products of both alleles are detectable A and B antigens in an AB individual
Amorphic or silent allele The allele produces no detectable functional product A common O allele with a frameshift
Null phenotype All antigens assigned to a system are absent A phenotype produced by two nonfunctional alleles or by a separate regulator defect
Modifier or regulator A gene at another locus changes antigen expression FUT2 changes ABH and Lewis expression in secretions

The two alleles at a locus segregate so that each gamete receives one. Unlinked loci assort independently, while linked alleles can travel together as a haplotype. Most blood group alleles are codominant, so a heterozygous cell can display both inherited antigens. Most blood group genes are autosomal; X-linked loci produce a hemizygous pattern in a typical XY individual.

Missense, nonsense, insertion, deletion, and recombination variants can alter an epitope (the surface structure an antibody recognizes), reduce expression, or prevent production of a functional antigen or transferase. A common ABO O allele contains a single-nucleotide deletion that shifts the reading frame and produces an inactive glycosyltransferase.1,2

Family and population predictions

A pedigree can support dominant, recessive, or sex-linked inheritance and identify relatives whose samples may resolve an unusual phenotype. Incomplete family information, a new variant, penetrance, or serologic error can change the apparent pattern, so interpret pedigree evidence together with laboratory testing.

The common ABO model has three allele classes. A and B are codominant, and O is functionally silent. Phenotypes A and B each allow two common genotypes; O and AB have one common genotype each.

Phenotype Common genotype possibilities Red-cell antigens
A AA or AO A and residual H
B BB or BO B and residual H
AB AB A, B, and residual H
O OO H

For an AO × AO mating, each parent can transmit A or O. The four equally likely combinations are AA, AO, AO, and OO. The genotype ratio is 1:2:1. The expected phenotype distribution is 75% group A and 25% group O. The expectation describes many conceptions under the model; it cannot predict the type of one child.

Common mating combinations produce these phenotype sets:

Parental genotypes Possible offspring phenotypes
AA × OO A
AO × OO A or O
AO × BO A, B, AB, or O
AB × OO A or B
AB × AB A, B, or AB

The Hardy-Weinberg relationship estimates genotype frequencies from allele frequencies in a large, randomly mating population when mutation, migration, and differential survival have no meaningful effect on the locus. For two alleles with frequencies p and q:

p + q = 1

p2 + 2pq + q2 = 1

In a simplified two-allele RHD example, assume 9% of donors lack functional RHD on both haplotypes. Then q2 = 0.09, q = 0.30, and p = 0.70. Among 2,000 donors, the model predicts 980 with two functional haplotypes, 840 with one functional and one null haplotype, and 180 with two null haplotypes. Serology groups the first 1,820 donors as D-positive, although two genotype classes contribute to that phenotype. A three-allele system uses p + q + r = 1 and includes the three homozygous terms plus the three doubled heterozygous terms.

Blood group terminology

A blood group system contains one or more antigens controlled by a single gene or by a complex of closely linked homologous genes, and each system is genetically distinct. The International Society of Blood Transfusion (ISBT) maintains the official registry. Its September 2026 release recognizes 49 systems after the addition of JAMA as system 049.3

Each antigen in a system has a six-digit number. The first three digits identify the system and the last three identify the antigen. ABO antigen A is 001001. Related antigens whose system assignment is pending can enter a 200-series collection. The 700 series holds unassigned antigens whose prevalence is below 1%; the 901 series holds unassigned antigens whose prevalence exceeds 90%.4

System or collection Number Principal gene Antigens emphasized here
ABO 001 ABO A, B, A,B, A1
P1PK 003 A4GALT P1, Pk, NOR
Lewis 007 FUT3 Lea, Leb, and related Lewis antigens
H 018 FUT1, with FUT2 included in the system table H
I 027 GCNT2 I
Globoside 028 B3GALNT1 P, PX2, ExtB
Ii collection 207 Genetic assignment remains incomplete i and related antigens

Laboratory records keep genes, antigens, antibodies, and phenotypes distinct:

  • Gene symbols are italicized, such as ABO, FUT1, and A4GALT.
  • Antigen symbols are plain type, such as A, K, Fya, and Pk.
  • Antibody names begin with anti-, such as anti-Fya and anti-P1.
  • A single antigen can be recorded as present or absent, such as K+ or K−.
  • An antithetical pair appears in one set of parentheses, such as Fy(a−b+).
  • Numeric phenotypes use the system symbol, a colon, and antigen numbers, such as SC:−1,2.
  • Phenotypes from different systems are separated with semicolons, such as S+s+; K−; Fy(a+b−).

A null red cell can be especially useful in an antibody investigation. If plasma reacts with common cells and loses reactivity with a system-null cell, the absent system becomes a strong candidate for the antibody's target. Complete the investigation anyway, because null cells are rare and can differ from common cells in other antigens as well.

ABO and H

Antigen construction

ABO and H antigens are the terminal sugars of oligosaccharide chains on glycoproteins and glycolipids. A glycosyltransferase attaches each sugar in a defined linkage. Type 2 precursor chains predominate on red cells, while type 1 chains predominate in secretions. FUT1 adds fucose to a red-cell precursor to create H. An A or B transferase can then modify H. FUT2 creates H on type 1 chains in secretory tissues.5

Sugar additions that create ABO, H, and Lewis antigensSimplified terminal sugar chains retain their linkage labels. Type 2 is Gal beta 1-4 GlcNAc; type 1 is Gal beta 1-3 GlcNAc. FUT1 or FUT2 adds fucose alpha 1-2 to Gal to form H. A transferase adds GalNAc alpha 1-3 to that Gal; B transferase adds Gal alpha 1-3. H remains unmodified in group O. On type 1 chains, FUT3 adds fucose alpha 1-4 to GlcNAc, forming Lewis a from the precursor or Lewis b from type 1 H. Lewis b has two fucoses attached to different sugars. Functional FUT2 also supports soluble ABH; nonsecretors lack soluble ABH and Lewis b.GalGlcNAcGalNAcFucABO, H, and Lewis: terminal sugar additionsSimplified chains; the chain continues to the right.Red cells · type 2 chainType 2 precursorβ1-4FUT1Hα1-2β1-4A transferaseB transferaseAα1-2α1-3β1-4Bα1-2α1-3β1-4Group O: no active A/B transferase; H stays unmodified.No FUT1: no red-cell H substrate for A or B synthesis.Secretions · type 1 chainType 1 precursorβ1-3FUT2Hα1-2β1-3FUT3FUT3Le(a)β1-3α1-4Le(b)α1-2β1-3α1-4Type 1 H also supports soluble A/B through ABO transferases.Inactive FUT2: nonsecretor; no soluble ABH or Le(b).Gal: galactose · Fuc: fucoseGlcNAc: N-acetylglucosamine · GalNAc: N-acetylgalactosamine
The sugar added, its attachment site, and the order of transferase activity distinguish ABO, H, and Lewis antigens. The drawings show terminal chains rather than complete membrane glycans.5
Active gene product Sugar added Product
FUT1, H transferase L-fucose H on red cells
FUT2, secretor transferase L-fucose H in secretory tissues
A transferase N-acetyl-D-galactosamine A
B transferase D-galactose B

Group O cells retain abundant unmodified H. A and B cells retain smaller amounts because their transferases consume H as substrate. The relative red-cell H expression is commonly summarized as O > A2 > B > A2B > A1 > A1B. Neonatal ABH expression is weaker and less branched, then approaches adult expression during early childhood. Reagent strength, method, and the inherited allele affect the measured antigen density.6,5

Secretor status

A person with at least one functional FUT2 allele forms soluble H on type 1 chains in secretory tissues. The inherited ABO transferase then creates soluble A or B when the corresponding allele is present. A person with two nonfunctional FUT2 alleles lacks soluble ABH in saliva and other affected secretions. Red-cell ABH expression remains under FUT1 and ABO control.

ABO group of a secretor A in saliva B in saliva H in saliva
O Absent Absent Abundant
A Present Absent Present
B Absent Present Present
AB Present Present Present

Hemagglutination inhibition can demonstrate soluble antigen. Patient saliva is incubated with a known antibody, then indicator red cells are added. Soluble antigen neutralizes the corresponding antibody, so the indicator cells remain unagglutinated. Agglutination shows that active antibody remained. The method requires validated reagents, specimen preparation, and controls.

A1, A2, and weaker expression

A1 and A2 account for most group A phenotypes. A1 cells react with anti-A and the lectin from Dolichos biflorus. A2 cells react with anti-A and remain nonreactive with a properly controlled anti-A1 lectin. A2 transferase converts a smaller set of H structures, leaving more H on the cell. Ulex europaeus anti-H lectin therefore usually reacts more strongly with A2 cells than with A1 cells.1,5

Some A2 and A2B individuals produce anti-A1. It is usually a cold, naturally occurring antibody that appears as an extra reverse-grouping reaction. Thermal range determines its clinical importance. A newborn's weak and less-branched A expression can also produce anti-A1-lectin nonreactivity. A single neonatal lectin result leaves the subgroup unresolved.

Rare A and B alleles produce still weaker expression. Their results vary with reagent clones and methods, so the reaction pattern leads to additional testing under the laboratory procedure.

Phenotype pattern Common serologic clue Useful confirmation principle
A3 or B3 Mixed-field reaction with the corresponding typing reagent Repeat with controls and evaluate the mixed population
Ax or Bx Weak or absent routine reaction with stronger reactivity by selected reagents Adsorption and elution can demonstrate weak antigen
Am or Bm Little direct agglutination despite inherited transferase activity Secretions, molecular testing, or reference methods can resolve the type
Ael or Bel Antigen is usually undetectable by direct agglutination Adsorption and elution can demonstrate antigen

Cis-AB is a rare allele that can express A and B specificity from one chromosome. It often produces stronger A expression with weaker or mixed-field B expression and may place an unexpected weak anti-B in the plasma. Family or molecular study can distinguish this inheritance from ordinary A and B alleles carried on separate chromosomes.

Bombay and para-Bombay phenotypes

Classical Bombay, Oh, results when red cells lack functional FUT1 and secretions also lack functional FUT2. Their red cells lack H substrate, preventing inherited ABO transferases from forming A or B. Forward grouping resembles group O, yet the plasma contains anti-A, anti-B, and anti-H. The anti-H usually has a broad thermal range, activates complement, and reacts strongly with ordinary group O cells because those cells carry abundant H. Support the patient with compatible Bombay red cells, because the anti-H reacts strongly with ordinary group O cells.6,2,5

Para-Bombay phenotypes retain a source of small amounts of H, commonly through functional FUT2 with absent or markedly reduced FUT1 activity. Soluble ABH can adsorb onto red cells, and weak A or B may be demonstrable by adsorption and elution. Anti-H varies in strength and thermal range. Compatibility testing and reference-laboratory characterization guide selection because some examples react at 37 °C.

Discrepant ABO results

Forward grouping detects antigen on patient red cells. Reverse grouping detects expected antibodies in patient plasma. A discrepancy exists when those results fail to support one ABO interpretation. The weakest or unexpected reaction often identifies the affected side of the test. Check identity, labeling, reagents, centrifugation, cell suspension, and transcription first. Request a fresh specimen when those checks call for one.1

Pattern Mechanisms to consider Interpretive direction
Weak or missing reverse reaction Newborn age, reduced immunoglobulin, immunosuppression, plasma dilution Increase controlled antibody detection and review history
Weak or mixed-field forward reaction Weak ABO allele, transfusion or transplant, leukemia or other altered erythropoiesis Wash cells, review history, and use subgroup or molecular methods as indicated
Unexpected apparent B on group A cells Acquired B after bacterial deacetylation of the A determinant Compare the patient's plasma result, reagent formulation, and reference testing
Rouleaux or protein interference Increased plasma proteins, plasma expanders, or inadequately washed cord cells Microscopy, cell washing, and saline replacement distinguish true agglutination
Extra reverse reaction Anti-A1, anti-H, cold autoantibody, or an alloantibody against a reagent-cell antigen Use selected A1, A2, B, and O cells with an autocontrol and antibody investigation

Suppose patient cells react 3+ with anti-A and 0 with anti-B. Plasma reacts 2+ with A1 cells and 4+ with B cells, while O cells and the autocontrol are nonreactive. The forward result supports group A. The isolated extra reaction with A1 cells supports an A2 phenotype with anti-A1. Anti-A1 lectin and additional selected cells can test that explanation. Resolve the discrepancy before recording a final ABO type. Until then, emergency component selection follows the laboratory's validated policy.

Lewis

Lewis antigen expression reflects the interaction of FUT3 and FUT2 on type 1 chains. FUT3 can add fucose to the precursor to form Lea. When FUT2 acts first, it creates type 1 H, and FUT3 can then form Leb. Lea and Leb are separate products of these interacting pathways.5

Lewis-active glycolipids are made mainly in tissues, circulate in plasma, and adsorb onto the red-cell membrane. The red-cell phenotype can therefore change as the plasma environment changes.

Functional genes Principal substances in secretions Usual adult red-cell phenotype
FUT3 and FUT2 Lea, Leb, and ABH according to the ABO genotype Le(a−b+)
FUT3 with nonfunctional FUT2 Lea Le(a+b−)
Nonfunctional FUT3 with functional FUT2 ABH according to the ABO genotype Le(a−b−)
Nonfunctional FUT3 and FUT2 No Lea, Leb, or ABH Le(a−b−)

The Le(a−b−) red-cell phenotype permits more than one secretor genotype, so Lewis typing alone cannot establish secretor status. Weak-secretor alleles can produce Le(a+b+), a phenotype seen more often in some Asian populations. Cord cells express little Lewis antigen, and expression develops as circulating glycolipids become available. Pregnancy can temporarily weaken the red-cell phenotype. Transfused Lewis-positive cells can shed adsorbed antigen in a Lewis-negative recipient.

Anti-Lea and anti-Leb occur most often in people with the Le(a−b−) phenotype. They are predominantly IgM, frequently bind complement, and usually react below 37 °C. Soluble Lewis substance can neutralize antibody, and transfused cells can lose Lewis antigen. These features make hemolytic transfusion reactions uncommon. For an antibody reactive at 37 °C, select red-cell units compatible by the indirect antiglobulin test under the laboratory procedure. For a person with sickle cell disease and anti-Lea, anti-Leb, or anti-Leab, Canadian Blood Services recommends antigen-negative units together with the extended matching used for sickle cell disease.7

Anti-LebH reacts best when both Leb and abundant H are present, often with group O or A2 cells. Anti-LebL recognizes Leb across ABO groups. Lewis antigens are weak on fetal cells and most Lewis antibodies are IgM. These features generally exclude Lewis antibodies as causes of hemolytic disease of the fetus and newborn.

Ii

i and I describe a developmental change in poly-N-acetyllactosamine chains. i is the linear chain. The branching enzyme encoded by GCNT2 converts it to branched I. Cord red cells are i rich and I poor. During approximately the first 18 months of life, I increases toward adult expression and i falls to trace levels. Rare GCNT2 variants can preserve the adult-i phenotype.5,8

Feature I i
Chain structure Branched Linear
Strong expression Adult red cells Cord cells and adult-i cells
Typical antibody pattern Anti-I reacts more strongly with adult cells Anti-i reacts more strongly with cord or adult-i cells
Current classification I system 027 Ii collection 207

Low-level autoanti-I is common and usually reacts only at cold temperatures. A broad thermal range can allow reaction near body temperature, produce complement-mediated hemolysis, and interfere with ABO typing, antibody screening, and crossmatching. Anti-I commonly accompanies cold agglutinin disease and can appear transiently with Mycoplasma pneumoniae infection. Anti-i is associated with infectious mononucleosis and some lymphoproliferative disorders. Thermal amplitude and evidence of hemolysis carry more interpretive weight than a cold titer alone.

Accelerated or abnormal erythropoiesis can increase i expression on adult cells because less-mature red cells enter circulation. The finding can occur with leukemia, megaloblastic or hypoplastic anemia, thalassemia, sickle cell disease, and chronic hemolysis.

P1PK and Globoside

The historical P blood group was divided after its antigens were assigned to separate genes. The P1PK system contains P1, Pk, and NOR under A4GALT. The Globoside system contains P, PX2, and ExtB under B3GALNT1. These systems remain biochemically connected. A4GALT converts lactosylceramide to Pk, and B3GALNT1 converts Pk to P. A4GALT also creates P1 from paragloboside through a parallel branch.4,5,9

Phenotype Principal antigens on red cells Antibody that may occur
P1 P1, P, and PX2, with trace Pk None expected from this pathway
P2 P and PX2, with trace Pk Anti-P1
p PX2; lacks P1, Pk, and P Anti-PP1Pk
P1k P1 and Pk; lacks P and PX2 Anti-P and anti-PX2
P2k Pk; lacks P1, P, and PX2 Anti-P, anti-P1, and anti-PX2

Anti-P1 is commonly a naturally occurring IgM antibody in P2 individuals. It usually reacts best in the cold and lacks clinical significance at 37 °C. P1 expression varies among cells and can weaken during reagent-cell storage, which can hide an anti-P1. For an example that reacts at 37 °C, select compatible units under the laboratory procedure.

People with the rare p phenotype can produce anti-PP1Pk, a mixture directed against the missing P1, Pk, and P antigens. People with a Pk phenotype can produce anti-P. Anti-PX2 can accompany anti-P because Pk cells also lack PX2. These antibodies can include IgM and IgG, activate complement, and cause severe hemolytic transfusion reactions. They are also associated with recurrent early pregnancy loss. Compatible blood usually requires rare-donor resources.6,9

Autoanti-P is the Donath-Landsteiner antibody of paroxysmal cold hemoglobinuria. This biphasic IgG binds red cells during cold exposure and fixes complement, and warming lets complement lysis finish. The laboratory demonstrates that pattern with a properly controlled Donath-Landsteiner test. Its P specificity is distinct from alloanti-P made by a person whose cells lack P.

Practice

Check yourself 1 of 3

In the common ABO model, what is the probability that a child of an AO × AO pairing is group O?

Incorrect. AO children make up 50%, and AO types as group A.

Incorrect. AA and AO children together make up 75%, and all of them are group A.

Correct. Each parent passes A or O with equal probability, giving AA, AO, AO, and OO. Only OO is group O, so 1 of 4 combinations, or 25%.

Review this section

Check yourself 2 of 3

Which enzyme activity forms H antigen on red-cell type 2 chains, the substrate that A and B transferases modify?

Incorrect. FUT2 creates H on type 1 chains in secretory tissues, the source of soluble ABH in saliva and other secretions. Red-cell ABH depends on FUT1.

Correct. FUT1 adds L-fucose to the red-cell type 2 precursor to form H, and an inherited A or B transferase then adds its sugar to H. In classical Bombay, with FUT1 and FUT2 both inactive, the red cells lack H, so A and B cannot form.

Incorrect. FUT3 adds fucose to type 1 chains and forms the Lewis antigens, Lea from the precursor and Leb from type 1 H.

Review this section

Check yourself 3 of 3

A patient's red cells type as group O. The plasma strongly agglutinates group O reagent cells and group O donor cells at 37 °C, and the autocontrol is nonreactive. Which explanation fits?

Incorrect. An autoantibody such as anti-I would also react with the patient's own cells, and this autocontrol is nonreactive. Anti-I also reacts best in the cold.

Correct. Bombay red cells lack H and type as group O, but the plasma contains anti-A, anti-B, and anti-H. The anti-H has a broad thermal range and reacts strongly with H-rich group O cells, so red-cell support requires compatible Bombay units.

Incorrect. Anti-A1 reacts with A1 reagent cells. Group O cells carry no A antigen, so anti-A1 leaves them unagglutinated.

Review this section

References
  1. International Society of Blood Transfusion. ISBT Blood Group Database. Accessed August 26, 2026. Back to text
  2. Dean L. Blood Groups and Red Cell Antigens. National Center for Biotechnology Information; 2005. Back to text
  3. International Society of Blood Transfusion. ISBT Blood Group Database, September 2026 release, version 19. Updated September 1, 2026. Accessed September 7, 2026. Back to text
  4. International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology. Blood group terminology. Accessed September 7, 2026. Back to text
  5. Stanley P, Wuhrer M, Lauc G, Stowell SR, Cummings RD. Structures common to different glycans. In: Varki A, Cummings RD, Esko JD, et al, eds. Essentials of Glycobiology. 4th ed. Cold Spring Harbor Laboratory Press; 2022. Back to text
  6. Bloch EM, Campbell-Lee S, McKenna DH Jr, Montemayor-Garcia C, Schwartz J, Shaz B, Storry J, eds. Technical Manual. 22nd ed. AABB; 2026. Back to text
  7. Canadian Blood Services. Serological best practices. Updated November 7, 2025. Accessed August 26, 2026. Back to text
  8. Cooling L. An update on the I blood group system. Immunohematology. 2019;35(3):85-90. PMID: 31621365. Back to text
  9. Stenfelt L, Hellberg Å, Westman JS, Olsson ML. The P1PK blood group system: revisited and resolved. Immunohematology. 2020;36(3):99-103. doi:10.21307/immunohematology-2020-048 Back to text

You finished Blood Group Foundations and Carbohydrate Systems

Practice this topic

Back to top ↑

Saved lessonsReview and reuse

Enlarged figure